Global B2B Pharmaceutical Marketplace ยท Sourcing ยท Named-Patient Access
๐Ÿ’ฌ WhatsApp ยท Sign in ยท Register

Hepatitis โ€” Manufacturers, Suppliers & Exporters

PharmaTradz lists 22 Hepatitis products from verified GMP-certified manufacturers, suppliers and exporters worldwide, available as Tablet, Injection, Tablets, Lyophilized Powder For Injection and more. Commonly sourced molecules include Lamivudine Stavudine & Nevirapine Tablets, Diptheria Pertussis Tetanus (dpt)vaccine, Adefovir Dipivoxil. Buyers can compare specifications, request bulk quotes, and source with regulatory documentation (COA, GMP certificates, CTD/ACTD dossiers) for import into their market.

22
Products listed
8
Dosage forms
500+
Verified suppliers
100+
Countries served
Can't find the Hepatitis product you need?
Send us an RFP โ€” our team sources it from verified manufacturers and reverts with quotes.
Send RFP โ†’

Browse Hepatitis products

Lamivudine Stavudine & Nevirapine Tablets

Strength: 150mg + 40mg + 200mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Lamivudine Tablets

Strength: 100 mg, 150 mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Lamivudine Tablets

Strength: 100 mg, 150 mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Lamivudine Zidovudine & Nevirapine Tablets

Strength: 150mg + 300mg + 200mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pakยฎ (US); Viekiraxยฎ + Exvieraยฎ (EU)

View Details Get Enquiry

Pegylated Interferon Alpha-1a

Strength: 120 mcg, 150 mcg, 180 mcg

Form: Injection

Reference Brands: Pegasysยฎ (US & EU), PegIntronยฎ (EU)

View Details Get Enquiry

Ribavirin

Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetolยฎ, Copegusยฎ, Virazoleยฎ(EU & US)

View Details Get Enquiry

Sofosbuvir

Strength: 400 mg

Form: Film-coated Tablets

Reference Brands: Sovaldiยฎ (EU & US)

View Details Get Enquiry

Sofosbuvir / Velpatasvir

Strength: Sofosbuvir 400 mg + Velpatasvir 100 mg

Form: Tablet

Reference Brands: Epclusa (EU & US), Velpanat (india)

View Details Get Enquiry

Tenofovir Alafenamide (TAF)

Strength: 25 mg TAF per tablet

Form: Tablet

Reference Brands: Vemlidy (EU & US), Genvoya (India)

View Details Get Enquiry

Tenofovir Disoproxil Fumarate(TDF) tablets

Strength: 300 mg

Form: Oral tablets

Reference Brands: Viread (EU & US), Truvada (India)

View Details Get Enquiry

Thymosin Alpha 1

Strength: 1.6 mg/vial

Form: Lyophilized Powder for Injection

Reference Brands: Zadaxinยฎ (EU & US)

View Details Get Enquiry

Frequently asked questions about Hepatitis

PharmaTradz lists GMP-certified manufacturers, suppliers and exporters supplying Hepatitis products. Every supplier passes KYC business checks, and GMP certificates and export history are verified before a Verified mark appears on their profile.

Hepatitis products on PharmaTradz are available as Tablet, Injection, Tablets, Lyophilized Powder For Injection, Oral Tablets, Oral Solution. Specific strengths and pack sizes are listed on each product page.

Open any product and click "Get Enquiry", or send an RFP describing the molecule, strength, destination market and quantity. PharmaTradz matches your requirement to verified suppliers able to serve that market and returns structured quotes.

Yes. Many listings include dossier availability in CTD, EU-CTD or ACTD format, with bioequivalence data where applicable. Dossier licensing and out-licensing opportunities can be requested through the same enquiry process.

Suppliers on PharmaTradz export to 100+ countries across Asia, Africa, Latin America, MENA, the EU and CIS. Share your destination market in the enquiry and we match suppliers with the right registrations and export experience. Controlled substances are supplied strictly against valid import and export permits.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.